In obesity management, conventional interventions, such as lifestyle modification and traditional pharmacotherapy, demonstrate limited efficacy in patients with moderate to severe obesity, and sustained weight loss is difficult to achieve
10.1016/j.joca.2024.06.011 199
For biopharma executives, this serves as a reminder of the importance of resilience and adaptability in drug development
PMC6073405 BPC-157 angiogenic signaling VEGFR2AkteNOS activation, nitric oxide bioavailability, FAK-paxillin cell-anchoring cascade, anti-cytokine modulation: PMC8275860 TB-4 / TB-500 G-actin sequestration and threshold-saturation mechanism actin-monomer binding, cytoskeletal mobilization for cell migration, mass-action pharmacodynamics requiring bolus dosing: PubMed 12581423 TB-4 Ac-SDKP anti-fibrotic fragment N-terminal tetrapeptide (fragment 14) released by meprin- and POP processing
Within this context, metabolic stability may depend on proportionality between substrate availability and pharmacologically induced metabolic demand